Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths-Reference-Cited by-同舟云学术

Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths

Published:2023-08 Issue:6 Volume:125 Page:152058
ISSN:0065-1281
Container-title:Acta Histochemica
language:en
Short-container-title:Acta Histochemica

Author:

Karkon-Shayan Sepideh,Aliashrafzadeh Hasan,Dianat-Moghadam Hassan,Rastegar-Pouyani Nima,Majidi Mohammadreza,Zarei Mahdi,moradi-vastegani Sadegh,Bahramvand Yaser,Babaniamansour Sepideh,Jafarzadeh Emad

Publisher

Elsevier BV

Subject

Cell Biology,Histology,General Medicine

Reference121 articles.

1. Neurokinin-1 receptor (NK-1R) antagonists: potential targets in the treatment of glioblastoma multiforme;Afshari;Curr. Med. Chem.,2021

2. Tissue distribution and ontogeny of sulfotransferase enzymes in mice;Alnouti;Toxicol. Sci.,2006

3. Resveratrol in cancer therapy: from stimulation of genomic stability to adjuvant cancer therapy: a comprehensive review;Amini;Curr. Top. Med. Chem.,2022

4. Heat shock protein vaccines against gliossblastoma: from bench to bedside;Ampie;J. Neurooncol,2015

5. Athar M., Back J.H., Kopelovich L., Bickers D.R., Kim ALJAob, biophysics. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. 2009;486(2):95–102.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activin A-Targeted Therapy in Cancer: An Updated Review on Challenges and Opportunities in Clinical Translation;Current Pharmaceutical Design;2024-08-27

2. Phytocompounds and Nanoformulations for Anticancer Therapy: A Review;Molecules;2024-08-09

3. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

4. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

5. The Role of Oxidative Stress in the Occurrence of Neurological Diseases and Cancer;Clinical Cancer Investigation Journal;2024